A local church is deploying handwashing stations across town. Photo by Nijalon Dunn

When the coronavirus forced the closure of restaurants, stores, and community centers, it disproportionally affected the health of a population of people: The homeless.

Homeless individuals are acutely vulnerable amid the public health and hygiene concerns due to the coronavirus pandemic, says Houstonian Nijalon Dunn. These communities of people have been left without immediate access to soap and clean water, especially with the closure of local businesses whose restrooms sometimes served as individuals' only sources of clean water.

"[Local businesses are] where people were able to use the restroom, wash their hands and have access to soap and water," Dunn says. "Take public restrooms away, now you have an increase in public urination and people using the restroom outside. Not only that, but people aren't washing their hands because of a lack of education and awareness about social distancing and hygiene practices."

Observing this effect of the virus, a group of Houstonians pulled together their skills and resources to provide handwashing stations across the city for Houston's homeless population.

Rise Houston Church, a local organization servicing inner-city Houston, is behind the initiative. Eager to help the community during the coronavirus pandemic, Rise Houston's pastor Stan DePue proposed the idea of building and distributing handwashing stations that would provide clean water and soap to homeless communities.

Dunn paired used his photography and filmmaking skills for a great cause when partnering with Rise Houston: Clean Hands. Dunn, a member of Rise Houston and founder of Black Visa Creative, a Houston company specializing in creative and commercial portraits that help small businesses tell their stories, knew that he could elevate DePue's project's reach and awareness through photojournalism.

"For us to have the impact and raise the support we needed, I knew that we needed to be documenting this [project]. So [Stan] and I partnered," Dunn says.

The idea evolved into an initiative with 10 sinks deployed across the city of Houston. According to Rise Houston's website, the sinks cost $300 to install. The church is looking for support in funding and maintaining the sinks — more information on giving back is available online.

DePue and his congregation are running the project's operation and physically constructing the sinks, and Dunn overseeing the project's documentation and awareness.

"We've been working with boots on the ground, creating partnerships so that we have strategic locations [for sinks] and know that they'll serve the best purpose in the areas where we place them," Dunn says.

After sink locations were identified across Houston, Rise Houston: Clean Hands volunteers delivered and set up the sinks on-site, each complete with a seven-gallon water tank, a water dispenser foot pump, soap and paper towel dispensers, trash bags, and signs that encourage the six-feet-apart social distancing rule.

"In order to stop the spread of coronavirus and flatten the curve, we needed to bring innovation to the way we serve our homeless brothers and sisters during this time," Dunn says.

A striking observation from Dunn's experience with this project, and the individuals he has worked and conversed with, has been how grateful people have been to learn about and be exposed to hygienic resources and practices, Dunn says.

"One of the greatest assets of the storyteller is knowing when to put the camera down. Some of the places we go to are some of the most vulnerable places in the city," Dunn says. "When we go into these homeless camps, I need to know when to put the camera down and live and exist with the person I talk to."

Through these interpersonal encounters, the teamwork of Rise Houston: Clean Hands volunteers and Dunn's innovative approach to communicating about this issue, the initiative has been able to sustain maintenance of the sinks and further spread hygienic awareness to Houstonians.

Letting hygiene sink in

Photo by Nijalon Dunn

Rise Houston: Clean Hands has deployed 10 outdoor sinks across Houston.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”